The Bredesen Protocol™
Next Generation Protocol developed by the Inventors of MEND

The Protocol provides a comprehensive personalized program designed to improve cognition and reverse the cognitive decline of SCI, MCI, and early Alzheimer’s disease. Continued research and testing by Dr. Bredesen began by evolving MEND into The Bredesen Protocol™, which has identified new and previously unrecognized causes of Alzheimer’s disease.

Additional Information

Click on the items below for a brief introduction to the title subject and links to the complete reference.

Reversal of cognitive decline: A novel therapeutic program

August 22, 2017

Inhalational Alzheimer’s disease: An unrecognized—and treatable—epidemic

August 22, 2017

Metabolic profiling distinguishes three subtypes of Alzheimer’s disease

August 22, 2017

Another Role for ApoE?

August 22, 2017

Direct Transcriptional Effects of Apolipoprotein E

August 22, 2017

Prionic Loops, Anti-Prions, and Dependence Receptors in Neurodegeneration

August 22, 2017

Next generation therapeutics for Alzheimer’s disease

August 22, 2017

Reversal of Cognitive Decline in Alzheimer’s Disease

August 22, 2017

On the Cover of Business in Savannah

January 15, 2014

A Balancing Act – Could the Secret Happy Aging Lie in Hormones?

January 15, 2014

Amazing Medicine: Biodential Hormones

January 15, 2014

Hormone Replacement Attracts Men

January 15, 2014

© 2019 Institute For Personalized Medicine